Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Chronic Diseases and Translational Medicine|April 18, 2019
Current advances in Hodgkin's lymphomaJoseph Vadakara, Benjamin AndrickJournal of the Advanced Practitioner in Oncology|February 5, 2021
Gilteritinib: A Novel FLT3 Inhibitor for Relapsed/Refractory Acute Myeloid LeukemiaDennis Marjoncu, Benjamin AndrickJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 14, 2022
Smaller but more frequent dosing of cefepime in the treatment of febrile neutropeniaLindsay Okubo, Benjamin Andrick, Ricky Rampulla, et al.Clinical Lymphoma, Myeloma & Leukemia|October 3, 2022
Oral Antineoplastics in Acute Myeloid Leukemia: A Comprehensive ReviewArpita Gandhi, Benjamin Andrick, Julianne Darling, et al.The Annals of Pharmacotherapy|January 18, 2021
Cancer-Associated Venous Thromboembolism Treatment With Anti-Xa Versus Weight-Based Enoxaparin: A Retrospective Evaluation of Safety and EfficacyKayla Hart, Benjamin Andrick, Stacey Grassi, et al.Innovations in Pharmacy|August 21, 2024
Using a Preceptor Development Series in Writing and Publication to Improve Residency Research ManuscriptsDaniel Longyhore, Eric A Wright, Sarah Krahe Dombrowski, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 16, 2018
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O TrialAmber B Clemmons, Julianne Orr, Benjamin Andrick, et al.Transplantation and Cellular Therapy|February 21, 2022
The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework AnalysisBenjamin Andrick, Lorraine Tusing, Laney K Jones, et al.Pageof 1